Federal Research Institute Of Pediatric Hematology, Oncology And Immunology

This study tested a combination of two drugs, secukinumab and dupilumab, in 15 children with severe Netherton syndrome, a rare genetic skin disorder. The goal was to see if the treatment is safe and helps control the disease. Results focus on overall survival and event-free survi…